Colorectal Cancer Market Size, Growth rate 2020 to 2027 - Natera, Amgen , Volitionrx Limited, Clinical Genomics Technologies, Novigenix SA

The market for colorectal cancer drugs is driven by frequent diagnostic tests and drug launches. Most of the major market players are involved in the manufacturing wide range of drugs and diagnostic tests that help in reducing the burden of colorectal cancer. For instance, in June 2019, Pfizer, Inc. launched ZIRABEV, a biosimilar to Avastin that helps in the treatment of five cancers, including colorectal cancer. Moreover, in September 2019, Lupin, an Indian pharmaceutical company, partnered with German-based Boehringer Ingelheim pharmaceutical company for the development of cancer drugs. The companies came together to develop and commercialize a drug based on the MEK inhibitor. This molecule is likely to target specific cancer cells and treat patients suffering from stomach and skin cancer.

Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006881/?openpr-10144

The Colorectal Cancer market is anticipated to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The market is anticipated to grow with a CAGR of 4.0% from 2019-2027.

The report provides trends prevailing in the global colorectal cancer market and the factors driving the market along with those that act as hindrances. The market for colorectal cancer is expected to grow, owing to factors such as increasing prevalence of colorectal cancer, new product launches and benefits offered by generic drugs. Moreover, growing pharmaceutical industry in emerging economies is likely to have a positive impact on the growth of the market in the coming years.

The rising pharmaceutical industry in the developing countries in the Asia Pacific region are creating better opportunities for significant market players to expand their business. This is a substantial reason for growth of the market in the forecast period. According to statistics India Brand Equity Foundation (IBEF) in April 2019, India is the largest provider of generic drugs worldwide. The Indian pharmaceutical industry supplies approximately 40% of generic demand in the US, with around 50% of world demand for multiple vaccines and 25 % of all medicines in the United Kingdom. The Indian pharmaceutical industrial sector was valued at US$ 33 billion in 2017 and is expected to expand at a CAGR of 22.4% over 2015–2020 to reach US$ 55 billion. In addition, India has a huge pool of scientists and engineers having the potential to grow the industry to an even higher level.

Company Profiles

Epigenomics AG
Novigenix SA
Clinical Genomics Technologies Pty Ltd.
EDP Biotech Corporation
Volitionrx Limited
Abbott Laboratories
Amgen Inc.
F. Hoffmann-La Roche AG
Bruker Corporation
Quest Diagnostics Incorporated
Natera, Inc.
Guardant Health

The global colorectal cancer market, based on modality, has been segmented into diagnosis type, therapy type, imaging type. The diagnosis type segment held the largest share of the market in 2018. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Furthermore, the companies are also focused on the development of new diagnostic tests that will help in the accurate detection of colorectal cancer. For instance, in December 2016, Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, introduced Colvera, a blood-based diagnostic test for colorectal cancer recurrence monitoring.

An outline of the regional analysis:

• Geographically, the report segments the Colorectal Cancer market into North America, Europe, Asia-Pacific, Southeast Asia, Middle East and Africa, South America.
• Contribution of each region to the overall market share, along with their growth rate forecast are mentioned in the report.
• Total sales and revenue generated by each regional market are illustrated.
• Comprehensive assessment of all opportunities and risks in the Colorectal Cancer market.

Buy Complete Report @ https://www.theinsightpartners.com/buy/TIPRE00006881/?openpr-10144

Reason To Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the colorectal cancer market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.